Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-04-17
2000-07-04
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 514169, 4241951, A61K 31715, A61K 3158, A61K 3578
Patent
active
060839325
ABSTRACT:
Disclosed is a ginseng extract, HT1001, comprising a saponin fraction which is about 20-50% by weight of the ginseng extract. The extract is also described in terms of ultraviolet absorbance peak display and total ion count peaks display. Pharmaceutical compositions and methods of use for the extract for treating brain disorders, depression, and improving memory are also disclosed.
REFERENCES:
patent: 4157894 (1979-06-01), Bombardelli
patent: 5137878 (1992-08-01), Pang et al.
patent: 5230889 (1993-07-01), Inoue
patent: 5589182 (1996-12-01), Tashiro et al.
patent: 5668154 (1997-09-01), Fink et al.
patent: 5776460 (1998-07-01), Kim et al.
Hou, J. P. The chemical constituents of ginseng plants. Comparative Medicine East and West, vol. V (2), pp. 123-145. (1977). No month found.
Battacharya et al. Anxiolytic activity of Panax ginseng roots: an experimental study. J. Ethnopharmacology 34, pp. 87-92. (1991). No month found.
Kim et al. Changes in chemical properties of red ginseng extract solution and physicochemical properties of precipitates formed during sterilization and storage. Koryo Insam Hakhoechi 20 (1), pp. 54-59. (1996). No month found.
Nabata et al. Pharmacological Studies of Neutral Saponins (GNS) of Panax Ginseng Root. Japan. J. Pharmacol. 23, pp. 29-41. (1973). No month given.
Schulten et al. Identification of Ginsenosides from Panax Ginseng in Fractions Obtained by High-Performance Liquid Chromatography by Field Desorption Mass Spectroscopy, Multiple Internal Reflection Infrared Spectroscopy and Thin Layer Chromatography. J. Chromatography. 212 (1), pp. 37-49. (Jul. 1981).
Benishin et al. Effects of Ginsenoside Rb1 on Central Cholinergic Metabolism. Pharmacology. 42, pp. 223-229. (1991). No month given.
Chepurnov et al. The Central Effects of Saponin Components and Polysaccharide Fractions form Korean Red Ginseng. Korean J. Ginseng Sci. 18 (3), pp. 165-174. (1994). No month given.
Chen, X. Cardiovascular Protection by Ginsenosides and their Nitric Oxide Releasing Action. Clinic. Exp. Pharmacol. Physiol. 23, pp. 728-732. (1996). No month found.
Salim et al. Ginsenoside Rb1 Regulates ChAT, NGF, and trkA mRNA Expression in the Rat Brain. Molec. Brain Res. 47(1-2), pp. 177-182. (Jul. 1997).
Benishin Christina
Huang Bu Han
Pang Peter
Shan Jaqueline
Sloley Brian
CV Technologies Inc.
Moran Majorie A
Woodward Michael P.
LandOfFree
Pharmaceutical compositions derived from ginseng and methods of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions derived from ginseng and methods of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions derived from ginseng and methods of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486723